MRNS
Marinus Pharmaceuticals Inc
Price:  
1.47 
USD
Volume:  
307,076.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS EV/EBITDA

-1860.6%
Upside

As of 2024-06-17, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 49.69 mil USD. MRNS's TTM EBITDA according to its financial statements is -132.50 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.6x - 11.1x 10.2x
Forward P/E multiples 11.0x - 12.2x 11.7x
Fair Price (26.07) - (26.12) (25.79)
Upside -1879.5% - -1882.8% -1860.6%
1.47 USD
Stock Price
(25.79) USD
Fair Price

MRNS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -0.38
2024-06-13 -0.37
2024-06-12 -0.39
2024-06-11 -0.41
2024-06-10 -0.41
2024-06-07 -0.40
2024-06-06 -0.39
2024-06-05 -0.41
2024-06-04 -0.36
2024-06-03 -0.38
2024-05-31 -0.36
2024-05-30 -0.37
2024-05-29 -0.41
2024-05-28 -0.39
2024-05-24 -0.34
2024-05-23 -0.31
2024-05-22 -0.30
2024-05-21 -0.32
2024-05-20 -0.33
2024-05-17 -0.32
2024-05-16 -0.31
2024-05-15 -0.32
2024-05-14 -0.32
2024-05-13 -0.33
2024-05-10 -0.32
2024-05-09 -0.34
2024-05-08 -0.36
2024-05-07 -0.42
2024-05-06 -0.38
2024-05-03 -0.39
2024-05-02 -0.37
2024-05-01 -0.38
2024-04-30 -0.35
2024-04-29 -0.35
2024-04-26 -0.35
2024-04-25 -0.36
2024-04-24 -0.36
2024-04-23 -0.36
2024-04-22 -0.38
2024-04-19 -0.34
2024-04-18 -0.35
2024-04-17 -0.36
2024-04-16 -0.27
2024-04-15 -0.31
2024-04-12 -2.89
2024-04-11 -3.05
2024-04-10 -3.12
2024-04-09 -3.24
2024-04-08 -3.17
2024-04-05 -3.00